Antibiotice S.A. Iasi is developing its business in the US and UK markets with new drugs associated with Covid-19

Must Read

The Romanian firefighters are present in France to support the French forces who are fighting the climacteric flames

By rbj Two C-17 Globemaster III aircraft from the Multinational Strategic Transport Unit and a C-27J Spartan aircraft of the...

ROCA Industry announces that its subsidiary Bico Industries will take over the majority stake in the Lithuanian company SmartTech AG

By rbj ROCA Industry, the holding company that brings together the construction materials companies in the ROCA Investments portfolio, announces...

Hungarians fear inflation, but also global recession. The opinion of the Central Bank of Budapest. Viktor Orban’s government expects inflation of 20% in 2022

By rbj Inflation could accelerate to around 20 percent in the coming months, said Barnabás Virág, vice president of Bank...

By Emea Riga
Against the background of the pandemic with the SARS-CoV-2 virus, while the Romanian hospitals and pharmacies market has substantially reduced its activity, the company Antibiotice S.A. Iasi identifies new business opportunities in international markets, such as the US and the UK.
In early July, Antibiotice made the first deliveries for two injectable anti-infective drugs used in the associative treatment of Covid-19, destined for hospitals in the United Kingdom and the US. These first deliveries are at the forefront of a contract with the authorities of these countries, following the winning of tenders organized by the British and American health systems. Other deliveries will follow, a total of 2.5 million bottles by the end of 2020. At this time, Antibiotice is already entered in the tender for 2021, the company aiming to continue long-term projects.
“With a representative portfolio of antibiotics, cardiovascular, anti-inflammatory or dermatological drugs, we managed in this difficult period for all of us, with many restrictions, to provide associative Covid-19 treatments both on the domestic and international markets. The deliveries were made considering first of all the coverage of the need for anti-infective drugs for the patients in Romania that we have been treating for 65 years “, said Delia Racoveanu, Marketing and Sales Director.
Accessing the UK market is part of a larger Antibiotics project for European markets, along with the Scandinavian states, Germany, Poland, Hungary, the Netherlands. In the USA, the company has been present for over 10 years, and with the entry into the market of this new product of superior generation, for which there are few manufacturers worldwide, Antibiotice has completed its portfolio of anti-infective drugs used in American hospitals.
“The fact that Antibiotice has become among the manufacturers accepted by the health systems of highly regulated and competing countries such as those in the European Union, Asia or USA, is important for us, because it is a recognition of the quality of medicines manufactured by Antibiotice Iași and implicitly a recognition of the performance of the Romanian pharmaceutical industry “, underlined Ms. Racoveanu.
Antibiotice S.A. Iasi is already present with these sterile injectable drugs in other international health systems such as Serbia, Vietam and the Republic of Moldova.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisement -
Latest News

The Romanian firefighters are present in France to support the French forces who are fighting the climacteric flames

By rbj Two C-17 Globemaster III aircraft from the Multinational Strategic Transport Unit and a C-27J Spartan aircraft of the...

ROCA Industry announces that its subsidiary Bico Industries will take over the majority stake in the Lithuanian company SmartTech AG

By rbj ROCA Industry, the holding company that brings together the construction materials companies in the ROCA Investments portfolio, announces that its subsidiary Bico Industries...

Hungarians fear inflation, but also global recession. The opinion of the Central Bank of Budapest. Viktor Orban’s government expects inflation of 20% in 2022

By rbj Inflation could accelerate to around 20 percent in the coming months, said Barnabás Virág, vice president of Bank Magyar Nemzeti. According to the...

The annual inflation rate stagnates. Will the Central Bank succeed in reaching the target for 2022? The BNR missed the inflation target in the...

By rbj The annual inflation rate in July 2022 compared to July 2021 is 15%, slightly decreasing from 15.1%, and compared to December 2021 it...

Topoloveni plum magic, wins another market in Asia, that of Vietnam, through the Discover European Treasures European program

By rbj "Sonimpex Topoloveni continues its presence at international fairs where it promotes the Romanian gastronomic tradition through the "Topoloveni Magiun din prune" Brand. The...
- Advertisement -

More Articles Like This

- Advertisement -